IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sands Capital Alternatives, LLC

Q2 2022 Holdings

Filed 2022-08-12 | 19 holdings | $19.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acumen Pharmaceuticals, Inc(ABOS)COM00509G209$16.1M3,417,07583.5%
Candel Therapeutics, Inc(CADL)COM137404109$2.6M811,73713.7%
Absci Corp.(ABSI)COM00091E109$192.0K57,8041.0%
Uipath Inc(PATH)COM CL A90364P105$69.3K3,811,7790.4%
Dice Therapeutics, Inc.COM23345J104$48.9K3,148,9700.3%
Doordash Inc(DASH)COM CL A25809K105$38.6K601,4540.2%
NU Holdings Ltd.(NU)COM CL AG6683N103$34.2K9,136,8350.2%
Samsara, Inc.COM CL BFDS1Q2O30$30.3K2,712,2560.2%
Snowflake Inc(SNOW)COM CL A833445109$29.8K214,6210.2%
Karuna Therapeutics, Inc.COM48576A100$21.9K172,8950.1%
10X Genomics, Inc.(TXG)COM CL A88025U109$21.8K481,7700.1%
Cincor Pharma, Inc.COM17240Y109$17.9K950,0000.1%
Olink Holding ABCOM680710100$10.7K705,5140.1%
908 Devices Inc(MASS)COM65443P102$6.7K326,4270.0%
Tarsus Pharmaceuticals Inc(TARS)COM87650L103$3.8K260,0000.0%
Repligen Corp.(RGEN)COM759916109$3.7K22,5440.0%
Samsara, Inc.(IOT)COM CL A79589L106$3.6K326,0000.0%
Taysha Gene Therapies Inc(TSHA)COM877619106$2.7K724,8730.0%
Spruce Biosciences IncCOM85209E109$1.4K787,0070.0%